| 1 | 6XMK |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
(1S,2S)-2-[(N-{[(4,4-difluorocyclohexyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
QYS |
 |
SHOW |
| 2 | 6YNQ |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
2-Methylenetetralone |
P6N |
 |
SHOW |
| 3 | 6XHM |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
(3S)-3-[(2S)-2-[(4-methoxy-1H-indol-2-yl)formamido]-4-methylpentanamido]-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butyl 2-cyanobenzoate |
V2M |
 |
SHOW |
| 4 | 6XQU |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
boceprevir |
U5G |
 |
SHOW |
| 5 | 6ZRU |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
boceprevir |
U5G |
|
SHOW |
| 6 | 6WNP |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
boceprevir |
U5G |
|
SHOW |
| 7 | 7COM |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
boceprevir |
U5G |
|
SHOW |
| 8 | 6XA4 |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
Calpain inhibitor II |
UXS |
 |
SHOW |
| 9 | 5RHB |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
Cov_HetLib030 |
USD |
 |
SHOW |
| 10 | 5RHC |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
Cov_HetLib053 |
USA |
 |
SHOW |
| 11 | 6XR3 |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
GRL-024-20 |
V7G |
 |
SHOW |
| 12 | 6M0K |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
~{N}-[(2~{S})-3-(3-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide |
FJC |
 |
SHOW |
| 13 | 6LZE |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide |
FHR |
 |
SHOW |
| 14 | 6XQT |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
Narlaprevir |
NNA |
 |
SHOW |
| 15 | 5RG2 |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
P0DTD1 |
NCL-00025058 |
T9M |
 |
SHOW |